808 



GENERAL INDEX 



Nephritis, uric acid in, iii, 437. 

 utilization of proteins in, iv, 314. 

 Nephrolysins, as cause) of nephritic 



toxicosis, iv, 396. 

 Nerve and endocrine control of glyco- 



genesis, glycogenolysis and glucoly- 



sis, iii, 257. 

 Nerve involvement, in dystrophia adi- 



posogenitalis, i, 866. 

 Nerves, magnesium in, iii, 323. 



stimulation of, by electricity, iii, 894. 

 Nerve stimulation, in administration 



of gland extracts, i, 38. 



Nervous activity, and the breeding 

 season, ii, 456. 



Nervous control of pancreas, i, 175. 



Nervous diseases, dermatoses associated 

 with, iv, 700. 



Nervous enteropathies, metabolism in, 

 iv, 637. 



Nervous manifestations, following cas- 

 tration, i, 177. 



of dystrophia adiposogenitalis, i, 894. 



Nervous structures, and their func- 

 tions, influence of internal secretion 

 of the testes upon, ii, 456. 



Nervous symptoms, in thyroid disease, 

 cerebral nerve paralysis, i, 354. 



epilepsy, i, 354. 



hysteria, i, 353. 



paralysis agitans, i, 354. 



paraplegia and hemiplegia, i, 353. 



tabes dorsalis, i, 354. 



tetany, i, 354. 



- Thomson's disease, i, 354. 

 tuberculosis, i, 355. 



of Addison's disease, ii, 294. 



of menopause, ii, 620. 



Nervous system, autonomic, symptoms, 

 of, in suprarenal insufficient, ii, 

 112. 



See Autonomic nervous system. 



central, action of internal secretions 

 on, i, 76. 



in cretinic degeneration, i, 461. 



control by, of epinephrin output, ii, 

 134. 



difference between autonomic and 

 central or cerebrospinal, i, 73. 



effect on, of undernutrition or fast- 

 ing, iv, 21. 



exophthalmic goiter, as due to 

 changes in the sympathetic, i, 312. 



as due to changes in the vegeta- 

 tive, i, 313. 



in cretinic degeneration, i, 466. 



in hypothyroidism, i, 389. 



in obesity, iv, 36. 



Nervous system, non-vegetative, action 

 of epinephrin on, pharmacodynamic, 

 i, 128. 



relation of tonus of, to internal se- 

 cretions of ductless glands, i, 74, 75. 



to parathyroid tetany, i, 531. 

 Nervous theory of Addison's disease, 



ii, 283. 

 Nervous tissue, mineral constituents 



of, iii, 306. 

 Neumann's experiments on protein 



minimum and optimum, iii, 402. 

 Neurasthenia, attributed to hypoad- 



renia, ii, 323. 



differentiated from exophthalmic 

 goiter, i, 359. 



from hypothyroidism, i, 425. 



from status thymicolymphaticus, 

 ii, 408. 



Neurin, as cause of nephritic toxicosis, 



iv, 396. 

 Neuritis, peripheral, differentiated 



from tetany, i, 681. 

 Neuro-endocrin control of intra-ocular 



tissue, ii, 769. 

 Neuro-endocrinology, ophthalmic, ii, 



757. 

 Neurogenic theory of exophthalmic 



goiter, i, 311. 

 Neurohypophysis, pigmentation in, i, 



777. 

 Neurological practice, ovarian therapy 



in, i, 158. 

 Neuromuscular disease, metabolism in, 



iv, 707. 



amytonia congenita, iv, 730. 



glucose supply, iv, 715. 



myasthenia gravis, iv, 730 



oxygen supply, iv, 709. 



progressive muscular atrophy, iv, 



730. 

 progressive muscular dystrophy, 



iv, 720. 

 source of energy for muscular 



contraction, iv, 709. 

 Neuromuscular symptoms, associated 



with thyroid disease, cerebral, i, 348. 



-motor symptoms, i, 348. 



sensory, i, 347. 



special senses, i, 348. 



Neuropathic edema, iv, 158. 

 Neuropathies, of postulated parathy- 



ropathic origin, chorea minor, i, 700. 



hyperparathyroid psychosis, i, 701. 



myasthenia gravis, i, 700. 



myoclonia, i, 700. 



Parkinson's disease, i, 698. 



Thompson's disease, i, 699. 



